Resources
Dive into the latest research insights, read up on new analysis tools, download case studies and white papers, and more.
Science Chat with Dr. Mallori Upshaw
Dr. Mallori Upshaw is the Director of Business Insights and Strategy at AstraZeneca, focusing on COVID-19 vaccines and immunotherapies. We spoke with Dr. Upshaw about her unique scientific journey and her experiences as a Black woman in STEM.
Read More
Silvin Golumbeanu, Naba Naufer, Ph.D. & Stefanie Morgan, Ph.D.
Large Language Models in Biology
Popularly used in chat interfaces like ChatGPT, Large Language Models (LLMs) are also being used to decode the various languages of biology.
Read More
Science Chat with Dr. Miranda Stratton
Check out our new series, “Science Chats”, with our first guest - Dr. Miranda Stratton!
Read More
Silvin Golumbeanu & Andrew Wight, Ph.D.,
Geneformer: Powering Drug Target Discovery with Network Biology
Geneformer is a tool developed by Theodoris et al. (Nature 2023) to predict tissue-specific gene network dynamics from single-cell transcriptomic data.
Read More
Naba Naufer, Ph.D.
AlphaFold: Applications for Biomedical Research
AlphaFold2 predictions have been used to probe questions at the heart of biomedical research, like how to design superior drugs, and how protein structure impacts disease.
Read More
Silvin Golumbeanu
Nobel Prize Day 2023: The Road to mRNA Vaccines
Drs. Karikó and Weissman’s research into mRNA and the immune system enabled the rapid development of vaccines against the SARS-CoV-2 virus.
Read More
Argus Athanas, Ph.D.
Using gnomAD to Drive Insights in Precision Medicine
The Genome Aggregation Database (gnomAD) is a collaborative effort to make data from large-scale sequencing projects publicly available for scientific use. Learn how to leverage the latest updates to the database, including new data from more than 700k individuals.
Read More
Stefanie Morgan, Ph.D.
Leveraging Public Datasets for Drug Discovery
The amount of public biological data available to researchers has exploded – but garnering insights requires appropriate infrastructure, expertise, and resources.
Read More
Stefanie Morgan, Ph.D.
Cell Painting with Watershed
The JUMP-Cell Painting Consortium combines images from nearly 120,000 chemical and 18,000 genetic perturbations with high-dimensional data analytics to streamline the drug discovery process.
Read More
Tommy Tang, Ph.D.
Variant Calling for Disease-Causing Mutations: The state-of-art process
Explore important considerations for effective and accurate variant calling in WGS/WES data.
Read More
Tommy Tang, Ph.D.
Unlock the Power of Genomics Data Analysis: Watershed's Seamless Cloud Computing Solution
Dr. Tommy Tang reviews the challenges with cloud computing in biotech, with an emphasis on concerns facing startups.
Read More
Watershed Informatics: The First Omics Bench for Modern Researchers
Watershed was founded to empower the world’s scientists to transform today’s big data into tomorrow’s precision medicines.
Read More
The Future of Human Gene Editing
Coming on 3/7, Watershed has the honor of hosting a webinar by groundbreaking genetics researcher Nancy L. Craig.
Read More
Advances in Big Data for Immuno-Oncology
Watch our webinar with cancer researcher Dr. Michelle Atallah to learn about the latest challenges and opportunities towards realizing the potential of big data in immunology and proteomics.
Read More
Dr. Stefanie Morgan's SciMed Podcast
Hear our own Stefanie Morgan's discussion with Adam Stasio and SciMed on Streamlining Bioinformatics.
Read More
New Automation Features for Streamlined Data Processing and Analysis
Our new workflow automation features help you accelerate high-volume data processing from upload to output.
Read More
Watershed's 2023 Year In Review
From closing Series A to processing over a petabyte of data, 2023 was a pivotal year in Watershed's growth. Check out this collection of some of our top highlights from this year.
Read More
Watershed Secures $14.5M Series A to Help Scientists Unlock Multi-Omic Insights for Drug Discovery
Financing will accelerate commercial roll-out of the company's cloud-based platform that provides a unified workspace for data-intensive biomedical research accessible by both biologists and bioinformaticians
Read More
Accelerating Multi-omics Analysis
Download our white paper to learn how Watershed is revolutionizing the use of big data in biology.
Read More
Developing a Next-Generation Gene Editing Platform with Watershed
A privately-held biotechnology company is developing a new category of gene therapies.
Read More
How Violet Therapeutics Scaled Their Target Discovery Platform with Watershed
Violet Therapeutics is a pre-clinical stage company leveraging their first-in-class platform, based on RABID-seq technology, to map and mine the cellular connectome at scale.
Read More
Building an Innovative Drug Discovery Platform with Watershed
Learn how a pre-clinical stage company is using Watershed to develop a novel approach to small molecule drug discovery.
Read MoreEvents Calendar
Join us for these upcoming conferences, webinars, and workshops.
FAQs
How much does a Watershed license cost?
We build out your plan depending on your unique needs and constraints. Book a demo today to tour the platform and discuss details with our team!
How do we get our data on the Watershed platform?
We can integrate data from anywhere – other clouds, links, local machines… the sky is the limit.
Where is Watershed headquartered?
We are based in Cambridge, Massachusetts, but we have bioinformaticians and engineers across the United States.